JPS58135878A - 新規アイラントン誘導体及びその製造法 - Google Patents

新規アイラントン誘導体及びその製造法

Info

Publication number
JPS58135878A
JPS58135878A JP56151124A JP15112481A JPS58135878A JP S58135878 A JPS58135878 A JP S58135878A JP 56151124 A JP56151124 A JP 56151124A JP 15112481 A JP15112481 A JP 15112481A JP S58135878 A JPS58135878 A JP S58135878A
Authority
JP
Japan
Prior art keywords
formula
compound
kbr
group
crystal form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56151124A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0121146B2 (en:Method
Inventor
Tadashi Honda
忠士 本田
Kayoko Imao
今尾　佳代子
Nobuo Nakatsuka
中塚　伸夫
Toshihiro Nakanishi
俊博 中西
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Priority to JP56151124A priority Critical patent/JPS58135878A/ja
Priority to AT82108776T priority patent/ATE24319T1/de
Priority to DE8282108776T priority patent/DE3274740D1/de
Priority to EP82108776A priority patent/EP0080570B1/en
Publication of JPS58135878A publication Critical patent/JPS58135878A/ja
Priority to US06/691,723 priority patent/US4665201A/en
Publication of JPH0121146B2 publication Critical patent/JPH0121146B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP56151124A 1981-09-22 1981-09-22 新規アイラントン誘導体及びその製造法 Granted JPS58135878A (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP56151124A JPS58135878A (ja) 1981-09-22 1981-09-22 新規アイラントン誘導体及びその製造法
AT82108776T ATE24319T1 (de) 1981-09-22 1982-09-22 Ailanthonderivate.
DE8282108776T DE3274740D1 (de) 1981-09-22 1982-09-22 Ailanthone derivatives
EP82108776A EP0080570B1 (en) 1981-09-22 1982-09-22 Ailanthone derivatives
US06/691,723 US4665201A (en) 1981-09-22 1985-01-15 Ailanthone derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56151124A JPS58135878A (ja) 1981-09-22 1981-09-22 新規アイラントン誘導体及びその製造法

Publications (2)

Publication Number Publication Date
JPS58135878A true JPS58135878A (ja) 1983-08-12
JPH0121146B2 JPH0121146B2 (en:Method) 1989-04-19

Family

ID=15511884

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56151124A Granted JPS58135878A (ja) 1981-09-22 1981-09-22 新規アイラントン誘導体及びその製造法

Country Status (5)

Country Link
US (1) US4665201A (en:Method)
EP (1) EP0080570B1 (en:Method)
JP (1) JPS58135878A (en:Method)
AT (1) ATE24319T1 (en:Method)
DE (1) DE3274740D1 (en:Method)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6072882A (ja) * 1983-09-29 1985-04-24 Suntory Ltd 新規アイラントン誘導体
JPS60104093A (ja) * 1983-11-12 1985-06-08 Suntory Ltd アイラントン誘導体およびその製造法
US8557864B2 (en) 2007-09-19 2013-10-15 Nagoya Industrial Science Research Institute Agent having neurotrophic factor-like activity

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3371517D1 (de) * 1982-11-08 1987-06-19 Suntory Ltd Novel ailanthone derivative
JPH06783B2 (ja) * 1985-06-14 1994-01-05 塩野義製薬株式会社 新規抗潰瘍剤およびクワツシノイド類
US10967031B2 (en) 2010-12-28 2021-04-06 Kamedis Ltd. Synergistic herbal compositions with prebiotic properties for treatment of skin infections, allergies and inflammation
CN103533947A (zh) 2010-12-28 2014-01-22 卡梅迪斯有限公司 用于治疗和预防感染的植物提取物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5924997B2 (ja) * 1977-10-03 1984-06-13 日本新薬株式会社 アシル化２−〔３−（２−クロロエチル）−３−ニトロソウレイド〕−２−デオキシグルコピラノ−ス誘導体
US4203996A (en) * 1978-02-22 1980-05-20 The United States Of America As Represented By The Secretary Of Agriculture Synthetic cephalotaxine esters having antileukemic P388 activity
US4340726A (en) * 1980-03-14 1982-07-20 Newport Pharmaceuticals International, Inc. Esters

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6072882A (ja) * 1983-09-29 1985-04-24 Suntory Ltd 新規アイラントン誘導体
JPS60104093A (ja) * 1983-11-12 1985-06-08 Suntory Ltd アイラントン誘導体およびその製造法
US8557864B2 (en) 2007-09-19 2013-10-15 Nagoya Industrial Science Research Institute Agent having neurotrophic factor-like activity
JP5447954B2 (ja) * 2007-09-19 2014-03-19 公益財団法人名古屋産業科学研究所 神経栄養因子様作用剤

Also Published As

Publication number Publication date
ATE24319T1 (de) 1987-01-15
JPH0121146B2 (en:Method) 1989-04-19
EP0080570A2 (en) 1983-06-08
US4665201A (en) 1987-05-12
EP0080570B1 (en) 1986-12-17
EP0080570A3 (en) 1983-10-05
DE3274740D1 (de) 1987-01-29

Similar Documents

Publication Publication Date Title
Lavie et al. Constituents of Withania somnifera Dun. III. The side chain of withaferin A*, 1
Nutt et al. Branched-chain sugar nucleosides. III. 3'-C-methyladenosine
JPH07504921A (ja) 高コレステロール血症を治療するためのステロイドグリコシド
Lythgoe The taxus alkaloids
JPS58135878A (ja) 新規アイラントン誘導体及びその製造法
Munk et al. Actinobolin. I. Structure of actinobolamine
Khan et al. Clerodane diterpenes from Casearia corymbosa stem bark
Jenkins et al. Branched-chain sugar nucleoside. IV. 2'-Methyladenosine
Nakata et al. Stereoselective synthesis of the functionalized syn-1, 3, 5, 7-tetraol
YOSIOKA et al. Saponin and Sapogenol. III. Seeds Sapogenols of Thea sinensis L.(3). Theasapogenol E and Minor Sapogenols
Ansari et al. Isolation and characterization of two saponins from Fagonia indica
Hirata Toxic substances of Euphorbiaceae
JPS63218691A (ja) 新規な５糖類化合物及びその製造法並びに抗凝血及び抗血栓剤
Van der Klein et al. Highly regioselective ring opening of five-membered cyclic sulfates with lithium azide: synthesis of azido sugars
Barton et al. Investigations on the biosynthesis of steroids and terpenoids. Part II. Role of 24-methylene derivatives in the biosynthesis of steroids and terpenoids
Tsai et al. Briaviolide Q, a new briarane from the cultured Briareum violaceum
Pettit et al. Antineoplastic agents. 119. Isolation and structure of bryostatins 10 and 11
Andersen et al. Selective Transformations of the Ca “" Pump Inhibitor Thapsigargin
Fan et al. Eleven highly oxygenated and anti-inflammatory guaian-8, 12-olides from Hedyosmum orientale
Ackland et al. Studies in terpenoid biosynthesis. Part 35. Biosynthetic sequences leading to the diterpenoid aphidicolin in Cephalosporium aphidicola
Xing et al. Secotrijugins A− D, four highly oxidized and rearranged limonoids from Trichilia sinensis and their anti-inflammatory activity
Hurd et al. The Arylation of Glycosyl Halides by Phenyllithium
Ferrier et al. Photobromination of carbohydrate derivatives. Part 5. Preparation and reactions of (5 S)-1, 2, 3, 4-tetra-O-acetyl-5-bromo-β-D-xylopyranose; a new type of ‘double-headed’nucleoside
JPS5852283A (ja) 新規アイラントン化合物
HU176688B (en) Process for preparing 2,9-dioxa-tricyclo/4,3,1,0 high 3,7/decanes